All News about Clearmind Medicine IncVia GlobeNewswire
Clearmind Medicine CEO Issues Letter to Shareholders
April 09, 2024
Via GlobeNewswire
Clearmind Medicine Completed Type A Meeting with the FDA
January 10, 2024
Via GlobeNewswire
Via GlobeNewswire
Clearmind Medicine Announces 1-for-30 Reverse Share Split
November 21, 2023
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
Penticton Herald
Phone number: 250-492-4002
E-mail: csr@ok.bc.ca
Address: 186 Nanaimo Ave. W.
Penticton, BC V2A 1N4
© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.